262 related articles for article (PubMed ID: 22081475)
1. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review.
Ustun C; Savage NM; Gotlib J; Bhalla K; Manaloor E; George TI
Am J Hematol; 2012 Feb; 87(2):191-3. PubMed ID: 22081475
[No Abstract] [Full Text] [Related]
2. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
[TBL] [Abstract][Full Text] [Related]
3. Clonality and molecular pathogenesis of mastocytosis.
Akin C
Acta Haematol; 2005; 114(1):61-9. PubMed ID: 15995326
[TBL] [Abstract][Full Text] [Related]
4. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
5. Cytology of systemic mastocytosis.
Bain BJ; Marks AJ
Am J Hematol; 2009 Dec; 84(12):842. PubMed ID: 19787646
[No Abstract] [Full Text] [Related]
6. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
[TBL] [Abstract][Full Text] [Related]
7. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
[TBL] [Abstract][Full Text] [Related]
8. Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.
Stoecker MM; Wang E
Arch Pathol Lab Med; 2012 Jul; 136(7):832-8. PubMed ID: 22742558
[TBL] [Abstract][Full Text] [Related]
9. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML
Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
[TBL] [Abstract][Full Text] [Related]
10. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma.
Kim Y; Weiss LM; Chen YY; Pullarkat V
Leuk Res; 2007 Dec; 31(12):1749-54. PubMed ID: 17544505
[TBL] [Abstract][Full Text] [Related]
11. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
12. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
13. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
[TBL] [Abstract][Full Text] [Related]
14. [Isolated lymphadenopathy as the first presentation of systemic mastocytosis--description of two cases].
Kinkor Z; Síma R; Skálová A; Boudová L; Peková S; Dvoráková D; Dĕdic K; Kracík M; Janousek M; Michal M
Cesk Patol; 2006 Jan; 42(1):34-8. PubMed ID: 16506600
[TBL] [Abstract][Full Text] [Related]
15. Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease.
Zhao W; Bueso-Ramos CE; Verstovsek S; Barkoh BA; Khitamy AA; Jones D
Leukemia; 2007 Jul; 21(7):1574-6. PubMed ID: 17410189
[No Abstract] [Full Text] [Related]
16. Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient.
Kawakami T; Haga T; Soma Y; Nagae C; Kinoshita A
J Dermatol; 2014 Aug; 41(8):761-3. PubMed ID: 25099159
[No Abstract] [Full Text] [Related]
17. Systemic mastocytosis.
Ozdemir D; Dagdelen S; Erbas T
Am J Med Sci; 2011 Nov; 342(5):409-15. PubMed ID: 21629042
[TBL] [Abstract][Full Text] [Related]
18. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
[TBL] [Abstract][Full Text] [Related]
19. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
Horny HP; Sotlar K; Sperr WR; Valent P
J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
[TBL] [Abstract][Full Text] [Related]
20. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP
J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]